RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.21147%2Fj.issn.1000-9604.2018.01.06
https://w3id.org/ripe/ripe-kg/work/10.21147%2Fj.issn.1000-9604.2018.01.06
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1136%2Fbmj-2024-081557Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/10.21147%2Fj.issn.1000-9604.2018.01.06Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma |
ripekg:work/10.21147%2Fj.issn.1000-9604.2018.01.06Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma |
prism:doi |
10.21147/j.issn.1000-9604.2018.01.06 |
ripekg:work/10.21147%2Fj.issn.1000-9604.2018.01.06Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma |
dcterms:title |
Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma |
ripekg:work/10.21147%2Fj.issn.1000-9604.2018.01.06Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma |
rdf:type |
node1 |
ripekg:work/10.21147%2Fj.issn.1000-9604.2018.01.06Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.21147%2Fj.issn.1000-9604.2018.01.06Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma |
rdf:type |
rdfs:Resource |
ripekg:work/10.21147%2Fj.issn.1000-9604.2018.01.06Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma |
rdf:type |
owl:Thing |
ripekg:work/10.21147%2Fj.issn.1000-9604.2018.01.06Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma |
rdf:type |
prov:Entity |
ripekg:work/10.21147%2Fj.issn.1000-9604.2018.01.06Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma |
rdf:type |
ripe:WorkWork |
ripekg:work/10.21147%2Fj.issn.1000-9604.2018.01.06Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma |
owl:sameAs |
https://semopenalex.org/work/W2790665395 |